Ayesha Azraa, Riehle Carolyne, Leishangthem Lakshmi
University of Utah School of Medicine, Salt Lake City, UT, USA.
University of Connecticut Health, Department of Neurology, Farmington, CT, USA.
Eye Brain. 2025 Mar 19;17:1-11. doi: 10.2147/EB.S418923. eCollection 2025.
Visual Snow Syndrome (VSS) is characterized by the presence of dynamic, continuous, tiny dots in the entire visual field persisting for more than three months, with at least two associated symptoms- palinopsia, photopsia, photophobia, or nyctalopia. VSS was introduced as perpetual visual disturbance representing TV static, based on early case reports from 1995. Despite its recognition, VSS management remains vague as many cases are refractory to treatment. This literature review aims to provide a summary of all attempted treatments and efficacies to help physicians manage VSS.
The authors performed a search of articles, literature reviews, and case reports using PubMed and Google Scholar with the key words "visual snow" and "treatment". Forty-one publications were identified; however, 14 were excluded as they did not discuss treatment options or focused on medical conditions associated with visual snow, such as migraine with aura. 27 articles were found to be relevant (from 1999-2024) with treatments in patients officially diagnosed with VSS. Treatments included pharmacotherapy, tinted lenses, neuromodulation, and behavioral therapy.
Based on this review of 27 publications, benzodiazepines and lamotrigine had the best effect (71.4% and 61.5% of patients had an improvement of VS symptoms on each medication, respectively). Antidepressants and AV nodal blocking agents were frequently prescribed but were less effective. VS symptoms improved with filtered lenses combined with cognitive behavioral therapy. Most treatments only partially alleviate VSS or manage associated symptoms like headache and palinopsia, rather than the visual snow itself.
The subjective nature of VSS has posed challenges. Among pharmacological treatments, benzodiazepines and lamotrigine have the most favorable therapeutic ratio in managing VSS. FL-41 tinted lenses consistently provide symptom relief, with cognitive behavioral therapy showing promise as an emerging intervention. Due to the small sample size, further research is recommended to enhance the applicability of findings.
视觉雪综合征(VSS)的特征是在整个视野中存在动态、持续的微小亮点,持续超过三个月,且至少伴有两种相关症状——残影、闪光幻觉、畏光或夜盲。根据1995年的早期病例报告,VSS被引入作为一种持续的视觉障碍,表现为电视静态画面。尽管已被认识到,但VSS的治疗仍不明确,因为许多病例对治疗难治。本文献综述旨在总结所有尝试过的治疗方法及其疗效,以帮助医生管理VSS。
作者使用PubMed和谷歌学术搜索文章、文献综述和病例报告,关键词为“视觉雪”和“治疗”。共识别出41篇出版物;然而,14篇被排除,因为它们未讨论治疗选择或专注于与视觉雪相关的医学病症,如伴有先兆的偏头痛。发现27篇文章(1999 - 2024年)与正式诊断为VSS的患者的治疗相关。治疗方法包括药物治疗、有色眼镜、神经调节和行为疗法。
基于对27篇出版物的综述,苯二氮䓬类药物和拉莫三嗪效果最佳(分别有71.4%和61.5%的患者使用每种药物后VS症状有所改善)。抗抑郁药和房室结阻滞剂经常被处方,但效果较差。使用滤光镜结合认知行为疗法后VS症状有所改善。大多数治疗仅部分缓解VSS或管理相关症状,如头痛和残影,而非视觉雪本身。
VSS的主观性带来了挑战。在药物治疗中,苯二氮䓬类药物和拉莫三嗪在管理VSS方面具有最有利的治疗比率。FL - 41有色眼镜始终能缓解症状,认知行为疗法作为一种新兴干预措施显示出前景。由于样本量小,建议进一步研究以提高研究结果的适用性。